Trial Profile
Study of the Absolute Oral Bioavailability of BMS-791325 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2014
Price :
$35
*
At a glance
- Drugs Beclabuvir (Primary) ; Beclabuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 25 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Apr 2014 New trial record